Literature DB >> 9328312

Localization and cellular sources of activins in normal and fibrotic rat liver.

P J De Bleser1, T Niki, G Xu, V Rogiers, A Geerts.   

Abstract

UNLABELLED: Activins are dimeric proteins, members of the transforming growth factor beta (TGF-beta) gene superfamily, consisting of the beta-subunits of inhibin (betaA and betaB). Recently, it was shown that activin A (betaA:betaA) inhibits DNA replication and induces apoptosis in rat parenchymal cells in vitro and in vivo. Cryostat sections of normal livers and livers of rats treated with intraperitoneal injections of CCl4 were stained for the different inhibin subunits and desmin, a marker for stellate cells (SC). Staining for inhibin-alpha was invariably negative, both in normal and fibrotic rat liver. In normal liver, inhibin-betaA subunit immunoreactivity was localized in parenchymal cells (PC). Staining for inhibin-betaB was weaker but similarly distributed. In fibrotic livers, connective tissue septa were strongly immunoreactive for inhibin-betaA. Desmin-positive stellate cells (SC) accumulated in areas strongly immunoreactive for inhibin-betaA and several cells were positive for both desmin and inhibin-betaA. Staining for inhibin-betaB was weaker but similarly distributed. As above data pointed to a possible role for PC and SC, we examined by Northern blot analysis, the expression of inhibin-alpha, -betaA, and -betaB messenger RNA (mRNA) in total RNA extracted from freshly isolated SC and PC of normal and CCl4-treated liver and in cultured SC. Inhibin-betaA mRNA was predominantly expressed in PC of normal liver. Expression was lost in PC of CCl4-treated liver. Inhibin-betaB mRNA expression was induced in SC of CCl4-treated liver. Inhibin-betaA mRNA, and to a lesser extent, inhibin-betaB mRNA expression was rapidly induced in cultured SC. The presence of activin A in conditioned media of cultured SC was shown by Western blotting. Apoptotic cells, identified by terminal deoxy-transferase mediated X-dUTP nick end labeling (TUNEL)-staining, were found predominantly in and near the fibrotic septa. IN
CONCLUSION: 1) while activin A was constitutively expressed in PC of normal liver, its expression was lost in PC of fibrotic liver; 2) expression of activins was induced in activated SC; and 3) apoptotic cells were found predominantly near the septa, in support of the hypothesis that activin A, derived from activated SC in the septa, contributes to the induction of cell death in neighboring PC.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9328312     DOI: 10.1002/hep.510260416

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  16 in total

Review 1.  Anti-inflammatory defense mechanisms of Entamoeba histolytica.

Authors:  Raúl Silva-García; Guadalupe Rico-Rosillo
Journal:  Inflamm Res       Date:  2010-10-12       Impact factor: 4.575

2.  Expression changes of activin A in the development of hepatic fibrosis.

Authors:  X Huang; D G Li; Z R Wang; H S Wei; J L Cheng; Y T Zhan; X Zhou; Q F Xu; X Li; H M Lu
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

3.  Commensal Bacteria-induced Interleukin 1β (IL-1β) Secreted by Macrophages Up-regulates Hepcidin Expression in Hepatocytes by Activating the Bone Morphogenetic Protein Signaling Pathway.

Authors:  Nanda Kumar N Shanmugam; Kejie Chen; Bobby J Cherayil
Journal:  J Biol Chem       Date:  2015-10-29       Impact factor: 5.157

Review 4.  Activins and Inhibins: Roles in Development, Physiology, and Disease.

Authors:  Maria Namwanje; Chester W Brown
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-07-01       Impact factor: 10.005

5.  Activins and follistatins: Emerging roles in liver physiology and cancer.

Authors:  Emanuel Kreidl; Deniz Oztürk; Thomas Metzner; Walter Berger; Michael Grusch
Journal:  World J Hepatol       Date:  2009-10-31

6.  Activin A is an autocrine activator of rat pancreatic stellate cells: potential therapeutic role of follistatin for pancreatic fibrosis.

Authors:  N Ohnishi; T Miyata; H Ohnishi; H Yasuda; K Tamada; N Ueda; H Mashima; K Sugano
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

7.  Activin A and follistatin in patients with nonalcoholic fatty liver disease.

Authors:  Stergios A Polyzos; Jannis Kountouras; Athanasios D Anastasilakis; Georgios Α Triantafyllou; Christos S Mantzoros
Journal:  Metabolism       Date:  2016-07-25       Impact factor: 8.694

Review 8.  Activins and activin antagonists in hepatocellular carcinoma.

Authors:  Alev Deli; Emanuel Kreidl; Stefan Santifaller; Barbara Trotter; Katja Seir; Walter Berger; Rolf Schulte-Hermann; Chantal Rodgarkia-Dara; Michael Grusch
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

9.  Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors.

Authors:  J P Iredale; R C Benyon; J Pickering; M McCullen; M Northrop; S Pawley; C Hovell; M J Arthur
Journal:  J Clin Invest       Date:  1998-08-01       Impact factor: 14.808

10.  Regulation of activin receptor-interacting protein 2 expression in mouse hepatoma Hepa1-6 cells and its relationship with collagen type IV.

Authors:  Hong-Jun Zhang; Gui-Xiang Tai; Jing Zhou; Di Ma; Zhong-Hui Liu
Journal:  World J Gastroenterol       Date:  2007-11-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.